Pharma & Biotech

The biotechnology firm Asep Medical is moving forward with the development of its diagnostic and anti-biofilm technologies. To reach its...

The therapeutic landscape for chronic inflammatory bowel diseases (IBD) is on the cusp of a significant shift. For years, the...

After a multi-month rally, shares of biotechnology firm ImmunityBio are experiencing a notable correction. Investor sentiment has been dampened by...

Facing the impending loss of patent protection for its blockbuster drug Stelara in 2025, Johnson & Johnson has been under...

As Sangamo Therapeutics advances its gene therapy candidate for Fabry disease, investor focus is split between imminent regulatory milestones and...

Bayer, the German pharmaceutical and life sciences giant headquartered in Leverkusen, is currently steering through a period of significant international...

Tilray Brands unveiled a trio of strategic announcements this week, spanning pharmaceutical distribution, beverage launches, and international acquisitions. Despite these...

Anixa Biosciences is intensifying its strategic focus on a pair of clinical-stage oncology assets. In a recent update, the company’s...

Despite facing notable share price pressure since the start of the year, Danaher's management is projecting confidence through a significant...

Legend Biotech Corp has reached a pivotal financial turning point. The company's cell therapy, CARVYKTI, became profitable in the last...